I am a healthcare professional


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.

Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.

By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.

You can find out more about cookies by browsing our Privacy Policy.


For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

WCLC 2023

Coming soon
11:27 AM
Duration 10mins Nicoll 2
Five-year survival in patients with ES-SCLC treated with atezolizumab in IMpower133: IMbrella A extension study results
Stephen Liu, Rafal Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian Hochmair, Florian Huemer, Gilberto Castro Junior, Libor Havel, Reyes Bernabe Caro, Raffaele Califano, Gyorgy Losonczy, Jong-Seok Lee, Dariusz Kowalski, Zoran Andric, Andrea Veatch, Gregory Gerstner, Marta Batus, Madeena Siddiqui, Huafei Li, Wei Zhang, Barzin Nabet, Stefanie Morris, Martin Reck

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:17 AM
Duration 10mins Hall 406
IMpower151: Phase III study of atezolizumab + bevacizumab + chemotherapy in first-line metastatic nonsquamous NSCLC
Zhou C, Dong X, Chen G, Wang Z, Wu X, Yao Y, Zhang Y, Cheng Y, Pan H, Zhang X, Cui J, Wang L, Chen X, Li X, Wang Z, Wang Q, He J, Wang M, Yan I, Qian L, An A, Cai A, Wu Q, Ballinger B, Wang L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:42 PM
Duration 10mins Nicoll 2
Comparison of digital vs manual PD-L1 tumour cell scoring on SP263-stained whole imaging slides from IMpower110
Minu Srivastava, Hen Prizant, Daniel Ruderman, Jennifer Giltnane, Jake Conway, Stephanie Hennek, John Shamshoian, John Abel, Michael Montalto, Andy Beck, Ilan Wapinski, Tien Hoang, Marcus Ballinger, Reena Amin, Roy Herbst, Filippo De Marinis, Giuseppe Giaccone, Jacek Jassem, David Spigel

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:00 PM
Duration 5mins Hall 405C
IMpower010: exploratory analysis of tumour mutational burden and disease-free survival with adjuvant atezolizumab in NSCLC
Enriqueta Felip, Minu K. Srivastava, Martin Reck, Heather Wakelee, Nasser Altorki, Eric Vallieres, Rüdiger Liersch, Satoshi Oizumi, Hiroshi Tanaka, John T. Hamm, Steven McCune, Stefanie Morris, Luciana Molinero, Virginia McNally, Silvia Novello, Marcus Ballinger, Haocheng Li, Wei Zou, Barzin Y. Nabet, Elizabeth Bennett, Barbara J. Gitlitz, Caicun Zhou

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar